2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Disease
3
Prostatic Neoplasms
2
Hereditary Cancer
2
Colorectal Neoplasms
2
Sarcoma, Kaposi
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Neoplasms
1
Lung Neoplasms
1
Gynecologic Cancer
1
Genetic Diseases, Inborn
1
Development of the Virtual Biopsy
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Chronic Pain
1
Castleman Disease
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Brain Neoplasms
1
Anus Neoplasms
1
Adenoma
1
Interventions
Fluorouracil
219
Leucovorin
202
Oxaliplatin
192
Irinotecan
150
Bevacizumab
110
Capecitabine
94
Cetuximab
90
Folfox protocol
54
Chemotherapy, Adjuvant
36
Panitumumab
30
Colonoscopy
30
pembrolizumab
23
Drug Therapy
23
Nivolumab
22
Magnetic Resonance Spectroscopy
22
Gemcitabine
21
Blood Specimen Collection
20
Radiotherapy
19
Floxuridine
19
Biopsy
19
Neoadjuvant Therapy
18
Laparoscopy
18
IFL protocol
18
Early Intervention, Educational
18
Celecoxib
18
Surveys and Questionnaires
17
Surgical Procedures, Operative
16
Immunohistochemistry
16
Exercise
16
trifluridine tipiracil drug combination
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Diagnostic Tests, Routine
×
Clear all
NCT06990633
2025-05-25
LYNX
Izmir Ataturk Training and Research Hospital
Not yet recruiting
180 enrolled